Latest news
iBio, Inc. (NASDAQ:IBIO) Given Average Rating of "Buy" by Analysts - MarketBeatMarketBeat · Sun, 09 Aug 2026 08:27:43 GMTUpcoming & Recent IPO's - IPOs Calendar - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 02:01:18 GMTPrice to book forward of Pharos iBio Co., Ltd. – KRX:388870 - tradingview.comtradingview.com · Thu, 06 Aug 2026 16:06:15 GMTiBio Expands Must-have Cardiometabolic and Obesity Pipeline Investor through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio - Diario ASDiario AS · Wed, 05 Aug 2026 06:42:43 GMTIBIO 8-K & SEC Filings - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 01:28:37 GMTiBio (IBIO) awards 430,000 stock options to its Chief Medical Officer - Stock TitanStock Titan · Tue, 04 Aug 2026 20:02:09 GMTiBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:00:00 GMT